Erman Akkus: Oncpoll on NSCLC

Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X:

“One-question oncpoll

In a patient with clinically stage I/II Non-Small Cell Lung Cancer (NSCLC) but upstaged to N2 after surgery, what would be your adjuvant treatment regarding RT?

Here are the Options:

• Only ChT
• ChT and then RT always
• ChT and RT if high risk
• CRT

42.3% of people think chemotherapy (ChT) and radiation therapy (RT) should be used if there is a high risk of complications, 35.1% believe chemotherapy alone (Only ChT) is the best choice. 12.4% prefer both chemotherapy and radiation therapy together (CRT). 10.3% think chemotherapy followed by radiation therapy (ChT and then RT always) is the best approach every time.

Source: Erman Akkus/X